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An approach based on the polymerase chain reaction (PCR) was used to isolate additional members of the G-linked receptor family from a rat 
striatal gtI1 cDNA library. Priming with one degenerate probe corresponding to highly conserved consensus equences in the third transmembrane 
(TM) domain of 15 G-linked receptors and sequences in the phage vector resulted in one clone (G- 13) encoding a dopamine D2 receptor variant 
with a 29 amino acid insert in the third cytoplasmic loop. In addition, the amino acid sequence ncoded by clone G-36 contained conserved sequen- 
ces characteristic of the G-linked class of receptors and displayed sequence homology in TM domains with the &adrenergic receptor (48%). Two 
conserved serine residues in TM5 postulated to be part of a ligand binding site in the adrenergic receptor, suggests that G-36 encodes a catecholam- 
inergic receptor. Northern blot analysis contlrmed the expression of G-36 in rat brain, but not in kidney, heart and lung. Several strong hybridizing 
bands to G-36 were obtained in both human and rat genomic DNA. The general PCR strategy employed here should prove to be extremely useful 
for the isolation of other members of the G-linked receptor family. 
Polymerase chain reaction; Homology probing; D2 dopamine receptor; Receptor variant 
1. INTRODUCTION 
Dopamine D2 receptors are known to mediate the ac- 
tivity of adenylate cyclase, phosphatidyl inositol tur- 
nover and K+/Ca’+ channels (see [ 1,2] for review). One 
D2 dopamine receptor (D2R) has been cloned [3] and 
shares amino acid and topographical homology, par- 
ticularly in transmembrane (TM) domains, with other 
members of the G’-linked receptor family [3,4]. At a 
functional level, the cloned D2R inhibits the activity of 
adenylate cyclase in a pertussis-toxin sensitive manner, 
and binds dopaminergic agonists and antagonists with 
an appropriate pharmacological specificity [3,5]. 
In an attempt to ascertain whether there are D2R 
subtypes that specifically couple to diverse effector 
systems we employed a variation of the homology pro- 
bing approach [6-lo] that involves the polymerase 
chain reaction [l 1,121 and the use of one degenerate 
oligonucleotide primer with cDNA from a rat striatal 
library as template. We report here that amplification 
of nucleotide sequences between the degenerate probe 
and sequences in the phage vector has allowed for the 
isolation of two additional members of the G-linked 
receptor family. One clone was identified as a D2R 
variant with a 29 amino acid insert in the third 
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cytoplasmic loop. Another clone (G-36) contained se- 
quence information coding for part of a novel G-linked 
receptor protein that shares 48% sequence homology 
with the fl2AR in TM domains and appears to be 
catecholaminergic in nature. 
2. MATERIALS AND METHODS 
2.1. Oligonucleotides 
The oligonucleotides used in the PCR and for use as probes were 
synthesized at the University of Toronto facility at the Banting In- 
stitute. To design an oligonucleotide for use in the PCR, we aligned 
the amino acid sequence of 15 members of the G-protein-linked 
receptors. A degenerate oligonucleotide (TM) coding for 6 amino 
acids in a conserved sequence of transmembrane three was synthesiz- 
ed and contains a 128-fold degeneracy. One of the oligonucleotides 
in this mixture codes for six amino acids of the known D2R sequence 
(fig. 1). A second oligonucleotide (VI) for use in the PCR was based 
on the sequence of the hgtll vector (fig.1). BamHI linkers were in- 
cluded at the 5’ end of each oligonucleotide to facilitate subcloning. 
2.2. DNA amplification by PCR and subcloning 
DNA was extracted and purified from a hgtll rat striatal cDNA 
library (Clontech). In a total reaction volume of 100~1 the cDNA 
(100 ng) was submitted to 30 cycles of PCR (Cetus-Perkin Elmer) 
with 1 pg each of primers TM3 and VI. The timing used was 1.5 min 
at 93”C, 2 min at 55°C. and 4 min at 72°C essentially as described 
by Sakai et al. [12], followed by a 7 min extension at 72°C. An ali- 
quot of this reaction (10 ~1) was removed and reamplified for an ad- 
ditional 25 cycles under the same conditions. DNA from this reaction 
(50 ~1) was phenol extracted, ethanol precipitated, subjected to Gene- 
Clean (BIO lOl), digested with BarnHI and EcoRI, and elec- 
trophoresed in soft agarose (O.SCro). The DNA contained in 7 con- 
tiguous slices was subcloned into the BamHI/EcoRI site of the 
plasmid sp65 (Promega), transformed with AGI cells, and transfor- 
mants selected on ampicillin plates. 
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2.3. SMfhem* hwkffn Ma ing uM.l seqm?ncing 
~~~pre~~tjo~ of plasmid cDNA from 70 randomly selected coi- 
onies, was restriction digested and the DNA fragments prepared for 
Southern blotting [13]. Each plasmid was Gene-Cleaned and sequenc- 
ed (Sequenase, WSB). Total RNA, from various rat tissues was 
prepared by acid guanidinium thiocyanate xtraction [14], and Nor- 
thern blotted. Gligonucleotides and cDNA clones were labelled with 
32P as described X13]. 
3. RESULTS AND DISCUSSIGN 
The amino acid residues in the third TM domain of 
all G-linked receptors are highly conserved 141, To pro- 
be for D2R variants a degenerate oligonu~l~otide was 
prepared (TM3; a 24-mer of W&fold degeneracy). The 
sequence for this degenerate oligonucleotide (TM3) and 
the PCR strategy employed are depicted in fig.lA and 
1B. One of the oligonucleotides contained in the mix- 
ture codes for the known D2R 131 (fig.lB). Amplifica- 
tion of a rat striatal cDNA library was achieved using 
TM3 in conjunction with an oligonucleotide prepared 
from sequences in the Xgtll phage vector (VI). The 
underlined sequences at the 5 ‘-end of each 
oligonucleotide contains a restriction endonuclease site 
to facilitate subsequent subcloning of amplified PCR 
products. 
Fig.lC depicts an ethidium bromide stain of PCR 
amplified rat striatal cDNA fragments. Following elec- 
trophoresis and Southern transfer, nitrocellulose mem- 
branes were probed with a “P end-labeled oligonucleo- 
tide (5 ’ -CATGGTCTGGATCTCAAAGAACTT-3 ’ ) 
that codes for a portion of the third cytoplasm.& loop 
A 
of the D2 receptor (amino acids 311-318) 131, As il- 
lustrated in an adjacent lane of fig.lC, two fairly dif- 
fuse hybridizing bands of 850 and 750 bp were 
identified and these bands confirmed that the PCR con- 
ditions used were suitable for the amplification of D2 
receptor DNA. 
PCR amplified products ranging in size from 200 to 
1500 bp were subcloned into the plasmid sp65. 
Minipreparation of plasmids with subcloned inserts 
were Southern blotted and probed with the D2R 
specific oligonucleotide. One of these clones (G13) in- 
itially recognized by Southern blotting (fig.lD) coded 
for the D2 receptor, as revealed by nucleotide sequenc- 
ing [3]. In addition to the previously reported sequence 
of D2R [3 1, clone G13 contained a 29 amino acid insert 
(encoded by an 87 bp insert) whose deduced amino acid 
sequence and position within the third cytoplasmic loop 
is shown in fig.2. Recent evidence also suggests the ex- 
istence of a 87 bp insert of the D2 receptor in human 
pituitary and brain 1151. However, no sequence infor- 
mation on this insert or the position of the insert within 
the third cytoplasmic loop has been reported. The func- 
tional significance of the D2R variant in either rat or 
human is unknown, but it is tempting to speculate that 
these inserts may allow for D2 dopamine receptor 
regulation of other effector systems including PI tur- 
nover and ion channel activity. Receptor G-protein in- 
teractions have been postulated to involve N-terminal 
residues within the 3rd cytoplasmic loop of the recep- 
tor, connoting the 5th and 6th TM helices [16,X7]. 
6 
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Trl3 
1)2-i%: c A I s I D R v 
5’ CGGATCCTG;G;CATCAGC$T;GAC$G~TAC 3’ 
G 
kb 
1,636 - 
1.018- 
,566 - 
kb 
0.85 
Pig.1. (A) Strategy used in the PCR amplification of rat striatal hgtll cDNA hbrary with a primer to TM3 and one to sequences in the phage 
vector (VI). Inserts in the library are flanked by EcoRI sites (IQ (RI Sequences of oliionucleotide primers used in the PCR. D2R amino acid 
sequences encoded by the 24 base TM3 degenerate o~~onu~ieot~de is also shown. The underlined nudeotide sequence indicates the position of 
the BarnHI linkers. (C) Ethidium bromide stain of PCR amplified products and Southern blot depicting hybridizing bands to a [“P]labelIed 
oligonucleotide probe constructed to code for part of (amino acid sequence 311-318) the D2 receptor [3]. Size markers are indicated on the left. 
(D) Southern blot of clone G-13 (D2R variant). 
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Single strand sequencing of 36 randomly selected 
clones from the PCR revealed the presence of a clone 
(G-10) that contained 130 bases coding for deduced 
amino acid sequences that shared conserved consensus 
sites characteristic of G-linked receptors within the 3rd 
and 4th TM domain. Subsequent Southern blotting of 
the 70 randomly selected clones with G-10 revealed a 
larger clone (G-36) containing a 454 bp insert. The 
deduced amino acid sequence of G-36 and alignment 
with 15 other members of the G-linked family of recep- 
tors is illustrated in fig.3. 
Of all the cloned G-linked receptors aligned in fig.3, 
G-36 contains the longest 2nd extracellular loop of 27 
amino acids (fig.3). The functional significance of this 
loop for receptor mediated events has yet to be deter- 
mined. In addition, G-36 displays 48% sequence 
homology in TM domains with &AR, 40% and 38% 
with cvzAR and ~-HTIA receptors and 32% with the 
D2R. 
Recent site directed mutagenesis and pharmacophore 
mapping experiments on the &AR have suggested that 
two serine residues in the 5th TM domain are critical 
for agonist binding and activation of the receptor [18]. 
Moreover, these serine residues are conserved in G- 
linked receptors that bind catecholaminergic agonists, 
but not in those whose endogenous ligand does not con- 
tain a catechol moiety. As depicted in fig.3, G-36 has 
conserved serine residues (indicated by arrows) within 
the 5th TM domain and thus, would be predicted to 
belong to a catecholaminergic receptor family. At pre- 
sent it is difficult to ascertain whether G-36 represents 
an additional adrenergic receptor, D2R variant or 
possibly the Dl dopamine receptor. The fact that G-36 
only shares limited homology (<50%) within TM 
regions with other G-linked receptors would argue 
against it being an adrenergic receptor variant, since 
homologies >60% are observed between the various 
adrenergic receptor subtypes aligned in fig.3. 
Northern blots were prepared to examine the mRNA 
expression of G-36 in several tissues. As depicted in 
fig.4A, G-36 was expressed in brain but not in tissues 
from rat kidney, heart or lung (data not shown). 
Moreover, as seen in fig.4B, Southern blotting of 
digested human or rat genomic DNA revealed a 
Fig.2. A model illustrating the topographical structure of the rat D2R variant in the membrane. The position of a 29 amino acid insertion in 
the third cytoplasmic loop is shown. Also shown are potential N-linked glycosylation sites, two possible PIG4 phosphorylation sites in the third 
cytoplasmic loop and extracellular cysteine residues uspected to be involved in disulphide bonding in the equivalent position in the &AR [19]. 
The carboxyl tail is shown anchored to the plasma membrane via palmitic acid thioesterification to Cys4rs (a cysteine residue in the equivalent 
position of &AR is palmitoylated [20]). 
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Fig.4. (A) Total brain RNA (3Opg) was subjected to blot 
hybridization [13] using [32P]labeBed clone G-36 as a probe. 
Molecular weight markers are shown on the left. (B) Southern blot 
analysis of human and rat genomic sequences homologous to clone 
G-36. Human DNA was digested with PstI (lane l), Hind111 (lane 2), 
BumHI (lane 3) and &/II (lane 4) and rat DNA digested with PslI 
(lane 5) were subjected to electrophoresis and Southern hybridization 
[13]. Size markers are shown on the left. 
number of strongly hybridizing bands. These ex- 
periments confirm that transcripts corresponding to 
G-36 sequences exist in the rat and that sequences 
homologous to G-36 are present in the human genome. 
In any event, it is clear that the PCR based homology 
probing approach described here should be extremely 
useful in the isolation of additional members of the G- 
linked receptor family. 
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